Evidence-based · Patient-first · AASLD & EASL 2024–2025

Understand Your
Liver Results.
Know What to Do Next.

Free guides, interactive calculators, and comprehensive ebooks for patients navigating fatty liver disease, fibrosis, FibroScan results, and cirrhosis — written in plain language, backed by peer-reviewed research.

⚡ Open Liver Risk Calculator Browse Free Guides →
9 Clinical scores, one entry
14 Free evidence-based guides
5000+ Peer-reviewed references
Free No account required
Our Most Powerful Free Tool

Comprehensive Liver Risk Calculator

Most patients get one score at a time — a FIB-4 from their GP, a CAP from a radiologist, a FibroScan kPa from a hepatologist — but never see the full picture at once. This calculator changes that.

Enter your values once and get 9 validated clinical scores simultaneously, each with a plain-language interpretation and the clinical context behind it.

  • Steatosis detection via the Fatty Liver Index (FLI)
  • Fibrosis staging via FIB-4, NFS, APRI, SAFE Score & FNI
  • FibroScan-enhanced: LSM interpretation, AGILE 3+ & AGILE 4
  • MASLD risk classification with full clinical interpretation
  • Auto-calculated BMI and globulin from your inputs
  • Printer-friendly report — take it to your next appointment
  • CSV export in LLM-ready format for further analysis
⚡ Open Calculator — Free What is FIB-4? →
Scores calculated in a single entry
FIB-4 Index
Primary guideline-recommended fibrosis screening tool (AASLD 2023)
AGILE 3+ & AGILE 4
FibroScan-enhanced scoring for advanced fibrosis and cirrhosis
NFS
NAFLD Fibrosis Score — validated for metabolic fatty liver
APRI
AST-to-Platelet Ratio Index — simple, widely available
SAFE Score
2023 validated tool combining albumin, FIB-4 & LSM
FLI
Fatty Liver Index — steatosis prediction from BMI, waist, GGT & TG
FNI Score
Fibrosis-5 and Fibrosis-6 components for broader staging
LSM Interpretation
Your FibroScan kPa placed in clinical fibrosis staging context
Calculate All 9 Scores — Free →
Free Longitudinal Tracking — No Account Needed

Liver Health Dashboard

A single calculator gives you a snapshot. But liver disease is a journey — and what matters most is whether your numbers are trending better or worse over months and years. The Liver Health Dashboard was built for exactly that.

Upload your PDFs or images of blood tests, FibroScan reports, and ultrasound results and get a personalised, interactive dashboard that plots every marker over time — so you and your doctor can see the trajectory clearly.

  • Upload blood test PDFs or photos — values extracted automatically
  • Tracks LFTs, CBC, metabolic panel, FibroScan & imaging longitudinally
  • Interactive trend charts for ALT, AST, FIB-4, LSM (kPa), CAP, HbA1c & more
  • Fibrosis score history: see how your FIB-4, AGILE 3+, and APRI move over time
  • Medication tracker — log what you take and correlate it with lab trends
  • Annotate dates with events: weight loss, medication changes, procedures
  • Printer-ready summary report for your next hepatology appointment
  • 100% free for a limited time
📊 Open My Liver Dashboard — Free Just want a one-time calculator? →
What the dashboard tracks over time
📈 Liver Enzyme Trends
ALT, AST, GGT, ALP plotted visit-by-visit — spot flares and improvements instantly
đŸ”Ŧ Fibrosis Score History
FIB-4, AGILE 3+, APRI & NFS calculated at each visit — is your fibrosis progressing or improving?
đŸĢ€ FibroScan Timeline
LSM (kPa) and CAP (dB/m) charted across scans — with fibrosis stage overlaid
🩸 Metabolic Panel
HbA1c, fasting glucose, triglycerides, HDL/LDL — the metabolic drivers of liver disease
💊 Medication Log
Record medications alongside lab dates — see what’s working and what isn’t
đŸ–ŧī¸ Imaging History
Log ultrasound, CT, and MRI findings — track liver size, spleen, and steatosis grade
⚖ī¸ Weight & BMI Curve
Weight loss is the strongest intervention — see it correlated directly with your liver numbers
📋 Appointment Report
One-page printable summary of all trends, scores, and medications for your hepatologist
Start Tracking My Liver Health — Free →
Free Evidence-Based Guides

Deep-Dive Articles for Every Stage

Written for patients, referenced against current clinical guidelines. No medical jargon left unexplained.

View all guides →
Blood Tests

Liver Enzymes Explained: AST, ALT, ALP & GGT

Why liver enzymes rise, what patterns reveal about your specific condition, and what the De Ritis ratio tells clinicians at a glance.

Read guide
Blood Tests

Liver Function Tests: Bilirubin, Albumin & PT/INR

The tests that measure what your liver actually does — not just damage signals. Covers jaundice, low albumin, and elevated INR in liver disease.

Read guide
Fibrosis Scoring

What Is FIB-4? Score, Calculator & Clinical Interpretation

The first-line fibrosis screen recommended by AASLD and EASL. Understand your result, the indeterminate zone, and when FibroScan is the next step.

Read guide + calculate
Fibrosis Scoring

AGILE 3+ & AGILE 4: Cutoffs, Calculator & Interpretation

When FIB-4 is indeterminate and you have a FibroScan result, AGILE scores combine both for much more accurate fibrosis and cirrhosis staging.

Read guide + calculate
Elastography

FibroScan (VCTE): Probes, CAP Score & How to Read Your Result

M vs XL probe selection, CAP steatosis scoring, quality criteria (IQR/median), and the confounders that falsely elevate your liver stiffness measurement.

Read guide
⚡ Interactive Tool

9-Score Comprehensive Liver Risk Calculator

Calculate FIB-4, AGILE 3+, AGILE 4, NFS, APRI, SAFE, FLI, FNI, and LSM in one place. Instant interpretation. CSV export. Fully free.

Open calculator
The Liver Health Book Series

Go Beyond the Basics

Two comprehensive ebooks — from confusing lab results to a clear understanding of your diagnosis, and exactly what to do next. Written for patients. Backed by science.

1
Available Now

A Complete Guide to Liver Blood Tests

8 chapters · 136+ pages · 50+ tests explained · AASLD, EASL & Baveno VII 2024–2025

What’s inside
  • Liver enzymes: ALT, AST, ALP, GGT — patterns and clinical significance
  • True liver function: bilirubin, albumin, PT/INR
  • CBC findings: platelets, hemoglobin, NLR and what they reveal
  • Kidney tests & electrolytes — the liver–kidney connection
  • Metabolic markers: insulin resistance, cholesterol, HbA1c, uric acid
  • Liver cancer biomarkers: AFP, AFP-L3, PIVKA-II, GALAD score
  • Disease-specific tests: hepatitis B & C, autoimmune, iron overload
  • Prognostic scores: MELD, Child-Pugh, FIB-4, NFS, ELF, AGILE 3+, AGILE 4
$19 PDF · Lifetime access
Buy Now → Learn more
2
Available Now

A Complete Guide to Liver Imaging & Diagnosis

10 chapters · 180+ pages · Every imaging test explained · Includes 72-hour post-diagnosis action plan

What’s inside
  • Chapter 0: “You have fatty liver/cirrhosis. Now what?” — 72-hour action plan
  • Abdominal ultrasound: what “bright liver” means and grading systems
  • FibroScan (VCTE): M vs XL probes, CAP scores, quality criteria
  • Ultrasound alternatives: pSWE, 2D-SWE, FibroTouch
  • MRI, MRE & PDFF — the gold standard for fat and fibrosis
  • HCC surveillance: liver cancer screening and when ultrasound isn’t enough
  • Endoscopy and varices: preparation, procedure, and treatment
  • Invasive procedures: liver biopsy, HVPG, paracentesis — when and why
$19 PDF · Lifetime access
Buy Now → Learn more

đŸ“Ļ Get Both Books — Save $9

The complete patient library: blood tests, imaging, diagnosis, scoring systems, and a 72-hour action plan. Everything you need to understand your liver disease and have better conversations with your healthcare team.

Usually $38
$29
Get Both Books →
Free · No spam · Unsubscribe anytime

Stay Updated on Liver Health Research

New guides, calculator updates, and plain-language breakdowns of the latest MASLD & fibrosis research — delivered to your inbox.

Common Questions

Frequently Asked Questions

The questions patients ask most often — answered plainly, with links to the full guides for more detail.

MASLD stands for Metabolic-Associated Steatotic Liver Disease — the 2023 replacement name for NAFLD. It describes fat accumulation in more than 5% of liver cells in people with at least one cardiometabolic risk factor such as obesity, type 2 diabetes, high blood pressure, or dyslipidaemia. MASLD affects roughly one in four adults globally, ranging from fully reversible simple steatosis through MASH (steatohepatitis), advanced fibrosis, and cirrhosis. See all MASLD content →
FIB-4 is a blood-based score calculated from your age, AST, ALT, and platelet count. A score below 1.30 makes significant liver fibrosis unlikely and generally requires no further testing. A score above 2.67 suggests advanced fibrosis and warrants specialist referral and elastography (FibroScan or MRE). The zone between 1.30 and 2.67 is indeterminate — further testing such as FibroScan or ELF is typically needed. Full FIB-4 guide + calculator →
FibroScan (VCTE) measures liver stiffness in kilopascals (kPa). Your result maps to a fibrosis stage: roughly below 7–8 kPa (F0–F1, minimal), 7.9–9.6 kPa (F2, significant fibrosis), 9.6–13.6 kPa (F3, advanced), above 13.6 kPa (F4, cirrhosis). FibroScan also measures your CAP score (dB/m) for liver fat simultaneously. Results can be elevated by inflammation, recent meals, or cardiac congestion — always interpret with clinical context. Full FibroScan guide →
ALT (Alanine Aminotransferase / SGPT) is the most liver-specific enzyme — elevated ALT almost always signals liver cell injury. AST (Aspartate Aminotransferase / SGOT) is also found in heart, muscle, and kidneys, making it less specific. The AST/ALT ratio (De Ritis ratio) gives diagnostic clues: a ratio below 1 (ALT dominant) is typical of MASLD; a ratio above 2 (AST dominant) is classic for alcoholic liver disease; as cirrhosis develops, the ratio often reverses above 1 as ALT production falls. Full liver enzymes guide →
Yes — early MASLD is reversible. Sustained weight loss of 7–10% significantly reduces liver fat and inflammation. Studies show 10% weight loss can resolve MASH in up to 90% of patients and improve fibrosis stage in many. The earlier intervention begins — ideally before F3 fibrosis — the greater the benefit. Approved medications for MASH (including resmetirom) can also improve fibrosis independently of weight loss.
MELD (Model for End-Stage Liver Disease) uses creatinine, bilirubin, INR, and sodium to predict 90-day mortality in advanced liver disease and prioritise patients on the transplant waiting list. MELD 3.0 — the current version — adds a sex variable to address historical inequity in transplant access for women. A MELD below 10 suggests relatively stable, compensated disease; above 20 carries substantially elevated short-term mortality risk. MELD guide + calculator →